What is the PREDIMED MEDAS and why is it the standard?

The Mediterranean Diet Adherence Screener (MEDAS) is a 14-item yes/no questionnaire developed and validated by the PREDIMED (PREvención con DIeta MEDiterránea) Spanish research group. It was used as the primary adherence measure in PREDIMED — the largest Mediterranean diet intervention trial ever conducted (7,447 subjects, 4.8 year median follow-up, NEJM 2013). The trial showed a 30% reduction in major cardiovascular events (MI, stroke, CV death) in subjects assigned to Mediterranean diet with olive oil or nuts vs the control low-fat diet. MEDAS is the standard validated instrument because it was the specific tool that demonstrated benefit in the trial — alternative Mediterranean adherence scores exist but lack the same direct outcome evidence.

How big is the actual benefit of high vs low Mediterranean adherence?

Substantial — particularly for cardiovascular events. PREDIMED 2013 showed 30% relative risk reduction in MI/stroke/CV death for high-adherence vs control over ~5 years. The 2014 Sofi et al. meta-analysis (BMJ, 18 cohort studies, 4.4 million person-years) found each 2-point increase in Mediterranean adherence score was associated with 8% lower all-cause mortality, 10% lower CV mortality, 4% lower cancer incidence, and 13% lower neurodegenerative disease (Alzheimer's, Parkinson's). For prediabetes specifically, the 2020 Jannasch meta-analysis showed Mediterranean reduced T2D incidence by 19–23% vs control diets.

What's the difference between MEDAS and the Trichopoulou MDS score?

They're both valid Mediterranean adherence scales but designed differently. The Trichopoulou MDS (Mediterranean Diet Score, 2003) scores 9 components on tertile cutoffs (above/below median for the study population), giving 0–9 total. It's more research-oriented because the cutoffs require population-specific normalisation. MEDAS uses fixed yes/no questions with universal thresholds (e.g., "≥4 Tbsp olive oil per day yes/no"), making it usable in clinical settings without population data. MEDAS is faster (2–3 minutes) and now more commonly used in primary care; MDS remains the standard for cohort epidemiology.

Can I follow Mediterranean diet without olive oil — like with avocado oil?

Olive oil (especially extra-virgin) is the most evidence-supported single component of the Mediterranean diet. PREDIMED found additional benefit specifically from extra-virgin olive oil compared to refined olive oil, attributed to polyphenols that survive in unrefined oil. Avocado oil is similar in MUFA profile (~70% oleic acid) and would likely provide most of the same cardiometabolic benefit, but lacks the same direct trial evidence. The 2018 Mateljan and Wallace review concluded avocado oil is reasonable as a partial substitute but extra-virgin olive oil should remain the primary cooking and finishing fat where possible.

Does Mediterranean require wine? What if I don't drink alcohol?

No — and recent evidence increasingly questions whether wine adds meaningful health benefit at all. The classic Mediterranean pattern includes moderate red wine (1–2 glasses with meals), traditionally credited with cardioprotective effects via polyphenols. The 2018 Lancet Global Burden of Disease alcohol analysis concluded the safest level of alcohol is zero — earlier studies showing benefit may have suffered from "sick quitter" confounding (light drinkers compared to ex-drinkers who quit due to illness). Most modern Mediterranean recommendations make wine optional or omit it entirely. The food components (olive oil, fish, vegetables, legumes, nuts, whole grains) drive the cardiovascular benefit; the wine is not required.

Mediterranean Diet Score Calculator — PREDIMED MEDAS 14

The PREDIMED trial — why this score matters

The PREvención con DIeta MEDiterránea trial randomised 7,447 adults at high cardiovascular risk to one of three diets: Mediterranean with extra-virgin olive oil (1 L/week provided), Mediterranean with mixed nuts (30 g/day provided), or a low-fat control diet. After a median 4.8 years of follow-up, the trial was stopped early because both Mediterranean groups showed clear benefit. Major adverse cardiovascular events (MI, stroke, CV death) were 30% lower in the EVOO group and 28% lower in the nuts group vs control. The 2018 reanalysis after a methodological concern (some site clustering) reduced the effect size slightly but the benefit remained statistically significant and clinically meaningful. Estruch et al., NEJM 2013/2018.

What the 14 items capture

The MEDAS instrument was carefully designed to capture both the "do" components (olive oil, vegetables, fruit, fish, legumes, nuts, sofrito cooking technique) and the "avoid" components (red meat, butter/cream, pastries, sugary drinks) that define the Mediterranean pattern. The wine question (≥7 glasses/week) is the most controversial — recent evidence from the 2018 Global Burden of Disease analysis and the 2023 alcohol-mortality meta-analyses increasingly suggest no safe level of alcohol exists. Most modern Mediterranean recommendations omit the wine point entirely or make it optional.

Score interpretation

≥9 (high adherence): Mediterranean pattern is well-established. PREDIMED 30% CV event reduction at this level.
6–8 (moderate): Significant Mediterranean elements but with meaningful gaps. Each additional point above 6 reduces CV event risk ~6% (Sofi 2014 meta-analysis).
≤5 (low): Mediterranean pattern is mostly absent. Greatest improvement potential here — improving even 3–4 specific habits often raises the score 4+ points.

Highest-impact items to fix first

Not all 14 items contribute equally to the cardiovascular benefit. The 2018 PREDIMED sub-analyses identified the strongest individual contributors as:

Extra-virgin olive oil as primary fat — polyphenol content is the proposed mechanism beyond MUFA profile alone
Fish ≥3 servings/week — omega-3 EPA/DHA drives anti-inflammatory effects
Nuts ≥1 serving/week — MUFA, vitamin E, polyphenols
Vegetables ≥2 servings/day — fiber, potassium, polyphenols, nitrates
Legumes ≥3 servings/week — protein, fiber, glycemic load reduction
Limited red and processed meat — independent CVD and colorectal cancer risk reduction

If you scored low, prioritise these six. Items like "drink <1 sugary beverage/day" and "limited commercial pastries" matter too but are easier wins for most adults — they often don\'t require new shopping habits.

Related tools

Frequently asked questions

What is the PREDIMED MEDAS and why is it the standard?: The Mediterranean Diet Adherence Screener (MEDAS) is a 14-item yes/no questionnaire developed and validated by the PREDIMED (PREvención con DIeta MEDiterránea) Spanish research group. It was used as the primary adherence measure in PREDIMED — the largest Mediterranean diet intervention trial ever conducted (7,447 subjects, 4.8 year median follow-up, NEJM 2013). The trial showed a 30% reduction in major cardiovascular events (MI, stroke, CV death) in subjects assigned to Mediterranean diet with olive oil or nuts vs the control low-fat diet. MEDAS is the standard validated instrument because it was the specific tool that demonstrated benefit in the trial — alternative Mediterranean adherence scores exist but lack the same direct outcome evidence.
How big is the actual benefit of high vs low Mediterranean adherence?: Substantial — particularly for cardiovascular events. PREDIMED 2013 showed 30% relative risk reduction in MI/stroke/CV death for high-adherence vs control over ~5 years. The 2014 Sofi et al. meta-analysis (BMJ, 18 cohort studies, 4.4 million person-years) found each 2-point increase in Mediterranean adherence score was associated with 8% lower all-cause mortality, 10% lower CV mortality, 4% lower cancer incidence, and 13% lower neurodegenerative disease (Alzheimer's, Parkinson's). For prediabetes specifically, the 2020 Jannasch meta-analysis showed Mediterranean reduced T2D incidence by 19–23% vs control diets.
What's the difference between MEDAS and the Trichopoulou MDS score?: They're both valid Mediterranean adherence scales but designed differently. The Trichopoulou MDS (Mediterranean Diet Score, 2003) scores 9 components on tertile cutoffs (above/below median for the study population), giving 0–9 total. It's more research-oriented because the cutoffs require population-specific normalisation. MEDAS uses fixed yes/no questions with universal thresholds (e.g., "≥4 Tbsp olive oil per day yes/no"), making it usable in clinical settings without population data. MEDAS is faster (2–3 minutes) and now more commonly used in primary care; MDS remains the standard for cohort epidemiology.
Can I follow Mediterranean diet without olive oil — like with avocado oil?: Olive oil (especially extra-virgin) is the most evidence-supported single component of the Mediterranean diet. PREDIMED found additional benefit specifically from extra-virgin olive oil compared to refined olive oil, attributed to polyphenols that survive in unrefined oil. Avocado oil is similar in MUFA profile (~70% oleic acid) and would likely provide most of the same cardiometabolic benefit, but lacks the same direct trial evidence. The 2018 Mateljan and Wallace review concluded avocado oil is reasonable as a partial substitute but extra-virgin olive oil should remain the primary cooking and finishing fat where possible.
Does Mediterranean require wine? What if I don't drink alcohol?: No — and recent evidence increasingly questions whether wine adds meaningful health benefit at all. The classic Mediterranean pattern includes moderate red wine (1–2 glasses with meals), traditionally credited with cardioprotective effects via polyphenols. The 2018 Lancet Global Burden of Disease alcohol analysis concluded the safest level of alcohol is zero — earlier studies showing benefit may have suffered from "sick quitter" confounding (light drinkers compared to ex-drinkers who quit due to illness). Most modern Mediterranean recommendations make wine optional or omit it entirely. The food components (olive oil, fish, vegetables, legumes, nuts, whole grains) drive the cardiovascular benefit; the wine is not required.